SOURCE: Bellwether Report

May 10, 2005 12:42 ET

Today the Bellwether Reports Aggressive Digging Has Unearthed These 4 Gems: VRTX, EMMS, ADBL, and XOMA

NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by The Bellwether Report.

TORONTO -- (MARKET WIRE) -- May 10, 2005 -- The Bellwether Report is the leading online financial newsletter, focusing on small-cap emerging growth opportunities. We strive to introduce investors to truly undervalued opportunities in a time-friendly fashion, allowing for optimal entry points and profitable exit points. Today, we will be tracking the following companies to gauge the short-term sentiment of their market.

Vertex Pharmaceuticals (NASDAQ: VRTX); Emmis Communications Corp. (NASDAQ: EMMS); Audible Inc. (NASDAQ: ADBL); and Xoma Ltd. (NASDAQ: XOMA). Investors interested in any of the above-mentioned companies are invited to sample the Bellwether Report for 30 days complimentary, and receive a full report on the company of your choosing.

Vertex Pharmaceuticals is a biotechnology company engaged in the business of discovering, developing and commercializing small molecule drugs for serious diseases, including HIV and Hepatitis C. Early morning trading saw stocks trading up 14% following today's announcement that the company's VX-950, an investigational Oral Hepatitis C protease inhibitor displayed positive data for Hepatitis C.

Emmis Communications Corp. is a media company with radio broadcasting, television broadcasting and magazine publishing operations. Shares were up 18% after the company today reported that they may sell TV business to buy back stock.

Audible Inc. is a provider of digitally delivered spoken word audio on the web. The company sells membership-based spoken audio content, such as audio versions of books, newspapers, etc. Audible shares jumped 15% on better than expected quarter-one earnings.

Finally, we look at Xoma Ltd. They are a biopharmaceutical company that develops and manufactures products to treat immunologic and inflammatory disorders, cancer and infectious diseases. Shares were up 12% following yesterday's market close announcement of first-quarter results.

For a daily and up-to-date informative service featuring other exciting companies like those listed above, feel free to visit and sign up. Sixteen thousand subscribers have, why don't you? Remember... NO credit card needed!!

The Bellwether Report to date has not been compensated by any of the above-mentioned companies.

Contact Information